Sugar compositions for treating hemophilia A and/or von Willebrand disease

US9707269B2 · kind B2 · utility

Assignee

• CSL Behring AG · DE

Inventors

• Stefan Schulte · Marburg, DE
• Rolf SPIRIG · Bern, CH
• Sabine Zollner · Muri, CH
• Michael Moses · Weilmünster, DE
• Wilfried Wormsbaecher · Kirchhain, DE
• Hans-Arnold Stoehr · Wetter, DE

Key dates

• Filing date: Mar 15, 2013
• Grant date: Jul 18, 2017
• Expiry date: Mar 15, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compositions comprising an isolated sugar for use in the treatment of von Willebrand disease and/or hemophilia A, wherein the sugar is an accessible sugar residue derived from ABO(H) blood group antigen.